These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18785268)

  • 1. Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.
    Willemsen R; Chames P; Schooten E; Gratama JW; Debets R
    Cytometry A; 2008 Nov; 73(11):1093-9. PubMed ID: 18785268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
    Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
    Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
    Denkberg G; Reiter Y
    Autoimmun Rev; 2006 Apr; 5(4):252-7. PubMed ID: 16697965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
    Li J; Mookerjee B; Wagner J
    J Immunother; 2008 Jan; 31(1):81-8. PubMed ID: 18157015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes.
    Lamers CH; Sleijfer S; Willemsen RA; Debets R; Kruit WH; Gratama JW; Stoter G
    J Biol Regul Homeost Agents; 2004; 18(2):134-40. PubMed ID: 15471217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.
    Hammer MH; Meyer S; Brestrich G; Moosmann A; Kern F; Tesfa L; Babel N; Mittenzweig A; Rooney CM; Hammerschmidt W; Volk HD; Reinke P
    Eur J Immunol; 2005 Jul; 35(7):2250-8. PubMed ID: 15915543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
    Machlenkin A; Uzana R; Frankenburg S; Eisenberg G; Eisenbach L; Pitcovski J; Gorodetsky R; Nissan A; Peretz T; Lotem M
    Cancer Res; 2008 Mar; 68(6):2006-13. PubMed ID: 18339883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of T-cell epitopes for cancer immunotherapy.
    Kessler JH; Melief CJ
    Leukemia; 2007 Sep; 21(9):1859-74. PubMed ID: 17611570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of T cell specificity for immunotherapy of cancer.
    Willemsen RA; Debets R; Chames P; Bolhuis RL
    Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
    Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
    Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.
    Berry LJ; Moeller M; Darcy PK
    Tissue Antigens; 2009 Oct; 74(4):277-89. PubMed ID: 19775368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
    Pameijer CR; Navanjo A; Meechoovet B; Wagner JR; Aguilar B; Wright CL; Chang WC; Brown CE; Jensen MC
    Cancer Gene Ther; 2007 Jan; 14(1):91-7. PubMed ID: 17024231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
    Westwood JA; Murray WK; Trivett M; Haynes NM; Solomon B; Mileshkin L; Ball D; Michael M; Burman A; Mayura-Guru P; Trapani JA; Peinert S; Hönemann D; Miles Prince H; Scott AM; Smyth MJ; Darcy PK; Kershaw MH
    J Immunother; 2009 Apr; 32(3):292-301. PubMed ID: 19242371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of gene therapy in tumor adoptive immunotherapy].
    Wang C; Zhao Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):482-6. PubMed ID: 18610648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.